RhumbLine Advisers’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,441
Closed -$98K 3304
2022
Q1
$98K Buy
1,441
+244
+20% +$20.3K ﹤0.01% 2889
2021
Q4
$145K Buy
1,197
+15
+1% +$2.53K ﹤0.01% 2892
2021
Q3
$166K Buy
1,182
+51
+5% +$10.1K ﹤0.01% 2938
2021
Q2
$311K Buy
1,131
+151
+15% +$38.1K ﹤0.01% 2770
2021
Q1
$210K Buy
980
+11
+1% +$3.04K ﹤0.01% 2820
2020
Q4
$234K Buy
969
+109
+13% +$13.5K ﹤0.01% 2771
2020
Q3
$91K Sell
860
-29
-3% -$2.64K ﹤0.01% 2883
2020
Q2
$87K Sell
889
-127
-13% -$11.1K ﹤0.01% 2983
2020
Q1
$76K Hold
1,016
﹤0.01% 2824
2019
Q4
$83K Buy
1,016
+14
+1% +$1.57K ﹤0.01% 2889
2019
Q3
$122K Buy
1,002
+71
+8% +$9.76K ﹤0.01% 2855
2019
Q2
$167K Buy
931
+171
+23% +$27.6K ﹤0.01% 2835
2019
Q1
$122K Buy
+760
New +$150K ﹤0.01% 2835

Other funds holding EVLO